CIK: 0002013410 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $762,887 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MPLT | MAPLIGHT THERAPEUTICS INC | 3,226,400 | $56,672 | 7.4% | $16.75 | 0.0% | COM | 56565P103 |
| CBIO | CRESCENT BIOPHARMA INC. | 1,677,852 | $19,899 | 2.6% | $12.74 | 0.0% | COM | G2545C104 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RAPT | RAPT THERAPEUTICS INC | 1,833,333 (+432.6%) | $62,095 (+599.4%) | 8.1% | $26.66 | +16.5% | COM NEW | 75382E208 |
| VOR | VOR BIOPHARMA INC | 3,617,354 (+852.8%) | $47,315 (+155.8%) | 6.2% | $20.89 | -10.8% | COM NEW | 929033207 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ASTRIA THERAPEUTICS INC | 4,107,537 | $29,903 | 3.9% | $7.88 | — | — | 04635X102 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| REPL | REPLIMUNE GROUP INC | 2,808,368 (-32.5%) | $27,297 (+56.7%) | 3.6% | $11.28 | -24.7% | COM | 76029N106 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 9,198,900 | $322,697 | 42.3% | $9.56 | +280.5% | ORDINARY SHARES | N62509109 |
| DYN | DYNE THERAPEUTICS INC | 5,462,846 | $106,853 | 14.0% | $12.58 | +50.6% | COM | 26818M108 |
| ENGN | ENGENE HOLDINGS INC | 9,632,561 | $86,982 | 11.4% | $10.14 | -21.0% | COM | 29286M105 |
| ENGNW | ENGENE HOLDINGS INC | 2,878,148 | $8,519 | 1.1% | $0.63 | — | W EXP 10/31/2028 | 29286M113 |
| BCYC | BICYCLE THERAPEUTICS PLC | 3,468,430 | $24,556 | 3.2% | $18.38 | — | SPONSORED ADS | 088786108 |